一覧に戻る

タイトル
  • en Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase activation.
作成者
アクセス権 open access
主題
  • MeSH en Animals
  • MeSH en Cell Adhesion/physiology
  • MeSH en Cells, Cultured
  • MeSH en Extracellular Matrix Proteins/metabolism
  • MeSH en Fibroblasts/metabolism
  • MeSH en Focal Adhesion Protein-Tyrosine Kinases/metabolism
  • MeSH en Mice
  • MeSH en Phosphorylation
  • MeSH en Signal Transduction
  • MeSH en Tenascin/metabolism
  • MeSH en p38 Mitogen-Activated Protein Kinases/metabolism
  • NDC 499
内容注記
  • Abstract en Extracellular matrix glycoprotein tenascin-X (TNX) is the largest member of the tenascin family. In this study, we investigated the adhesive properties of TNX and the signaling pathway to be induced to mouse fibroblast L cells on TNX substrate. Approximately 45% of evaluable cells used in the cell adhesion assay were attached to purified TNX but did not spread and were rounded on TNX. The remaining 55% of cells were detached from the TNX substrate and were floating in the conditioned medium. In rounded cells on TNX, phosphorylation of focal adhesion kinase (FAK) was diminished compared with that in cells on control phosphate buffered saline (PBS). To better understand the pathways that lead to the detachment of cells on the TNX substrate, we examined phosphorylation of p38 mitogen-activated protein (MAP) kinase. Phosphorylation of p38 MAP kinase was observed in the rounded cells on TNX in a dose-dependent manner, and the maximum effect was observed at 30 min on TNX. Inhibition of p38 MAP kinase alpha expression by RNA interference partially suppressed the TNX-induced cell detachment. These results suggest that the p38 MAP kinase is a major mediator of TNX-induced cell detachment.
出版者 en The Pharmaceutical Society of Japan
日付
    Issued2009-10
言語
  • eng
資源タイプ journal article
出版タイプ VoR
資源識別子 HDL http://hdl.handle.net/2115/53700
関連
  • isIdenticalTo DOI https://doi.org/10.1248/bpb.32.1795
  • PMID 19801846
収録誌情報
    • PISSN 1347-5215
      • en Biological & pharmaceutical bulletin
      • 32 10 開始ページ1795 終了ページ1799
ファイル
コンテンツ更新日時 2023-07-26